Money & Markets

CoreWeave Burned $7.47 Billion in One Quarter, Now Eyes $4 Billion More Debt

CoreWeave's Q3: revenue up 169% to $3.66B, backlog at $132.5B, but free cash flow hit minus $7.47B and the current ratio sits at 0.44 as a $4B loan looms.

By Daniel Okafor

3 min read

CRWV Fell 50%, Rose 50% and Lost 20% in Weeks. Here's Its Chart
CRWV Fell 50%, Rose 50% and Lost 20% in Weeks. Here's Its ChartPexels / pixabay

What's News

  • CoreWeave posted a $1.27 GAAP loss per share on $3.66B Q3 revenue, up 169.1% year over year.
  • Quarterly free cash flow was minus $7.47B after $9.44B of capex against $1.98B operating cash flow.
  • Bloomberg reported CoreWeave plans to raise at least $4B via an investment-grade loan led by Morgan Stanley and MUFG.
  • CRWV fell nearly 50% from Oct. 13 to Nov. 5, rebounded ~50%, then eased ~20%.
  • Revenue backlog stood at $132.5B; 2026 capex guidance rose to $37B–$39B.

CoreWeave posted a $1.27 GAAP loss per share on $3.66 billion of revenue in its fiscal third quarter, and the deeper numbers explain why the stock has swung between a 50% collapse and a 50% rebound in a matter of weeks. The loss beat the Street's expectation of a $1.46 per-share loss. Revenue grew 169.1% year over year. The company also ended the quarter with a $132.5 billion revenue backlog, raised full-year revenue guidance to a $13 billion–$13.3 billion range against the Street's $12.9 billion model, and lifted its 2026 full-year adjusted operating income outlook to $1.28 billion–$1.38 billion — a 26% annual increase at the midpoint, according to Moomoo markets commentator Stephen "Sarge" Guilfoyle's analysis published on TradingView.

By Daniel Okafor

Why is the cash picture the real story?

The burn is the problem. CoreWeave generated $1.98 billion of operating cash flow in the quarter. Capital expenditure consumed $9.44 billion of that. The result: free cash flow of minus $7.47 billion for three months, down from minus $1.59 billion in the year-ago period, per the Moomoo analysis.

The balance sheet compounds the strain. The company held $5.59 billion in cash at quarter's end. Current assets of $10.81 billion sat against current liabilities of $24.39 billion, a figure that included $10.57 billion in short-term debt and $2.27 billion in deferred revenue. That produced a headline current ratio of 0.44 — or 0.48 adjusted for deferred revenue — against the 1.0 level many investors treat as the minimum acceptable. Total assets of $91.48 billion, almost all tangible, faced total liabilities less equity of $87.46 billion, including $36.3 billion of long-term debt. Short-term debt alone runs to nearly double the cash position.

What does the new debt plan involve?

More borrowing is coming. Bloomberg News reported shortly after earnings that CoreWeave plans to raise at least another $4 billion through an investment-grade loan, with Morgan Stanley and Mitsubishi UFJ Financial Group leading the potential deal. The banks plan to syndicate the loan to other financial institutions and qualified investors in phases, and marketing could begin as early as this week — though CoreWeave has not finalized its plans, Bloomberg said. The analysis notes the obvious tension: more debt could push the current ratio lower still.

CoreWeave also guided full-year 2026 capital expenditures to $37 billion–$39 billion, up from the prior $35 billion–$39 billion range — spending that its $5.59 billion cash balance cannot cover on its own.

What does the CRWV chart show?

The stock tells the same conflicted story. CRWV fell nearly 50% between its Oct. 13 high and its Nov. 5 low after questions arose about its financing, then rebounded roughly 50% around the well-received quarterly results — and has since eased about 20%, through Thursday afternoon, Nov. 12.

On the technical side, the stock broke down from a basing consolidation that lasted about a year and spanned an $80 range, losing its 21-day exponential moving average, its 50-day and 200-day simple moving averages in the process. The analyst sees roughly two-thirds of a bullish inverse head-and-shoulders reversal pattern forming. But the stock traded at $46.81 on Wednesday morning against a 21-day EMA at $58.10 — the level the analyst calls home ground for the swing-trading crowd.

The indicators split the difference. The Relative Strength Index sits close to neutral. The MACD has improved: the 9-day EMA histogram has moved above zero, a typical short-term positive, and the 12-day EMA has crossed above the 26-day EMA — though both lines remain in negative territory.

The setup leaves CoreWeave as a revenue machine with a 169% growth rate, a $132.5 billion backlog and a balance sheet that, in the analyst's words, many investors would see as remarkably weak — with the $4 billion loan decision, and the capex it funds, likely to determine which half of that equation the market prices next.

Source: tradingview.com

Share this article:

More from Daniel Okafor

Daniel Okafor

Show full bio

Correspondent covering money, funding and market shifts around entrepreneurship, startups and venture funding at Business Bearings.

2,360 articles

Related articles

« Previous articleNext article »